ID   ST32B_HUMAN             Reviewed;         414 AA.
AC   Q9NY57; Q6UXH3; Q8IY14;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   03-AUG-2022, entry version 157.
DE   RecName: Full=Serine/threonine-protein kinase 32B;
DE            EC=2.7.11.1;
DE   AltName: Full=Yet another novel kinase 2;
GN   Name=STK32B {ECO:0000312|EMBL:AAH38238.1}; Synonyms=YANK2;
GN   ORFNames=UNQ3003/PRO9744;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAB76471.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain {ECO:0000312|EMBL:CAB76471.1};
RX   PubMed=10700184; DOI=10.1038/73508;
RA   Ruiz-Perez V.L., Ide S.E., Strom T.M., Lorenz B., Wilson D., Woods K.,
RA   King L., Francomano C., Freisinger P., Spranger S., Marino B.,
RA   Dallapiccola B., Wright M., Meitinger T., Polymeropoulos M.H., Goodship J.;
RT   "Mutations in a new gene in Ellis-van Creveld syndrome and Weyers
RT   acrodental dysostosis.";
RL   Nat. Genet. 24:283-286(2000).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAQ88719.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAH38238.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-198.
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH38238.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   NOMENCLATURE.
RX   PubMed=12471243; DOI=10.1126/science.1075762;
RA   Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S.;
RT   "The protein kinase complement of the human genome.";
RL   Science 298:1912-1934(2002).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-35; GLY-198; HIS-244; VAL-310 AND
RP   THR-342.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q60592};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q60592};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q60592};
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:10700184, ECO:0000269|PubMed:15489334};
CC         IsoId=Q9NY57-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:12975309};
CC         IsoId=Q9NY57-2; Sequence=VSP_051997;
CC   -!- MISCELLANEOUS: [Isoform 2]: It is unsure whether Met-1 or Met-3 is the
CC       initiator. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ88719.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ250839; CAB76471.1; -; mRNA.
DR   EMBL; AY358353; AAQ88719.1; ALT_INIT; mRNA.
DR   EMBL; BC038238; AAH38238.1; -; mRNA.
DR   CCDS; CCDS3380.1; -. [Q9NY57-1]
DR   CCDS; CCDS77895.1; -. [Q9NY57-2]
DR   RefSeq; NP_001293011.1; NM_001306082.1. [Q9NY57-2]
DR   RefSeq; NP_060871.1; NM_018401.2. [Q9NY57-1]
DR   AlphaFoldDB; Q9NY57; -.
DR   SMR; Q9NY57; -.
DR   BioGRID; 120631; 1.
DR   IntAct; Q9NY57; 15.
DR   MINT; Q9NY57; -.
DR   STRING; 9606.ENSP00000282908; -.
DR   BindingDB; Q9NY57; -.
DR   ChEMBL; CHEMBL5912; -.
DR   DrugCentral; Q9NY57; -.
DR   iPTMnet; Q9NY57; -.
DR   PhosphoSitePlus; Q9NY57; -.
DR   BioMuta; STK32B; -.
DR   DMDM; 74761811; -.
DR   MassIVE; Q9NY57; -.
DR   PaxDb; Q9NY57; -.
DR   PeptideAtlas; Q9NY57; -.
DR   PRIDE; Q9NY57; -.
DR   ProteomicsDB; 83178; -. [Q9NY57-1]
DR   ProteomicsDB; 83179; -. [Q9NY57-2]
DR   Antibodypedia; 9281; 125 antibodies from 23 providers.
DR   DNASU; 55351; -.
DR   Ensembl; ENST00000282908.10; ENSP00000282908.5; ENSG00000152953.13. [Q9NY57-1]
DR   Ensembl; ENST00000510398.1; ENSP00000420984.1; ENSG00000152953.13. [Q9NY57-2]
DR   GeneID; 55351; -.
DR   KEGG; hsa:55351; -.
DR   MANE-Select; ENST00000282908.10; ENSP00000282908.5; NM_018401.3; NP_060871.1.
DR   UCSC; uc003gih.2; human. [Q9NY57-1]
DR   CTD; 55351; -.
DR   DisGeNET; 55351; -.
DR   GeneCards; STK32B; -.
DR   HGNC; HGNC:14217; STK32B.
DR   HPA; ENSG00000152953; Tissue enhanced (kidney, lymphoid tissue).
DR   neXtProt; NX_Q9NY57; -.
DR   OpenTargets; ENSG00000152953; -.
DR   PharmGKB; PA128394683; -.
DR   VEuPathDB; HostDB:ENSG00000152953; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   GeneTree; ENSGT00940000160490; -.
DR   HOGENOM; CLU_000288_63_5_1; -.
DR   InParanoid; Q9NY57; -.
DR   OMA; KQRIIHR; -.
DR   PhylomeDB; Q9NY57; -.
DR   TreeFam; TF313395; -.
DR   PathwayCommons; Q9NY57; -.
DR   SignaLink; Q9NY57; -.
DR   BioGRID-ORCS; 55351; 9 hits in 1105 CRISPR screens.
DR   ChiTaRS; STK32B; human.
DR   GenomeRNAi; 55351; -.
DR   Pharos; Q9NY57; Tchem.
DR   PRO; PR:Q9NY57; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q9NY57; protein.
DR   Bgee; ENSG00000152953; Expressed in secondary oocyte and 109 other tissues.
DR   ExpressionAtlas; Q9NY57; baseline and differential.
DR   Genevisible; Q9NY57; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..414
FT                   /note="Serine/threonine-protein kinase 32B"
FT                   /id="PRO_0000232413"
FT   DOMAIN          23..283
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          374..396
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        146
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q60592,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         29..37
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q60592,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         52
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q60592,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VAR_SEQ         1..47
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_051997"
FT   VARIANT         35
FT                   /note="G -> E (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041166"
FT   VARIANT         198
FT                   /note="R -> G (in dbSNP:rs3733182)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_025899"
FT   VARIANT         244
FT                   /note="R -> H (in dbSNP:rs35207488)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041167"
FT   VARIANT         310
FT                   /note="D -> V (in dbSNP:rs56259884)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041168"
FT   VARIANT         342
FT                   /note="K -> T (in dbSNP:rs55961955)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041169"
SQ   SEQUENCE   414 AA;  47883 MW;  8FCD58A67EF09B0E CRC64;
     MGGNHSHKPP VFDENEEVNF DHFQILRAIG KGSFGKVCIV QKRDTKKMYA MKYMNKQKCI
     ERDEVRNVFR ELQIMQGLEH PFLVNLWYSF QDEEDMFMVV DLLLGGDLRY HLQQNVHFTE
     GTVKLYICEL ALALEYLQRY HIIHRDIKPD NILLDEHGHV HITDFNIATV VKGAERASSM
     AGTKPYMAPE VFQVYMDRGP GYSYPVDWWS LGITAYELLR GWRPYEIHSV TPIDEILNMF
     KVERVHYSST WCKGMVALLR KLLTKDPESR VSSLHDIQSV PYLADMNWDA VFKKALMPGF
     VPNKGRLNCD PTFELEEMIL ESKPLHKKKK RLAKNRSRDG TKDSCPLNGH LQHCLETVRE
     EFIIFNREKL RRQQGQGSQL LDTDSRGGGQ AQSKLQDGCN NNLLTHTCTR GCSS
//
